Minutes of the Bacillary Congress of Geneva, 1952?

The Minutes of the Bacillary Congress of Geneva, 1952 is the official proceedings and policy recommendations of the international medical conference held in Geneva from 7 to 18 May 1952. The congress assembled delegates from thirty-seven nations, clinical bacteriologists, hospital administrators, and public health officials to standardize responses to bacterial infection in the absence of reliable systemic chemical treatment.

The immediate cause was the 1943 Sicily campaign, whose casualty records had circulated in medical literature through the late 1940s. Allied field surgical teams reported that post-operative infection proceeded to gangrene and septicaemia at rates comparable to the pre-1928 baseline despite the availability of the azo drugs. The observation forced recognition that sulfonamide therapy, effective for uncomplicated urinary and respiratory infection in controlled hospital settings, could not arrest systemic bacteraemia once infection had entered the bloodstream. The congress was called by the International Sanitary Commission of the League of Nations to formalize a unified doctrine before infection-control standards diverged beyond coordination.

The opening address by the French delegate emphasised that chemical treatment would remain limited to uncomplicated infections responding to the azo drugs. For the majority of serious bacterial disease — endocarditis, meningitis, post-operative bacteraemia, and sepsis following trauma — no systemic cure existed. The congress was therefore convened not to discover new treatment but to accept this fact and organize prevention as the only reliable strategy.

The minutes record substantial disagreement over the degree to which prevention could substitute for treatment. The Soviet delegation argued that improved nutrition and living standards would reduce infection incidence. The American delegates countered that high-income populations still suffered bacterial disease and that prevention required institutional rather than social change. This dispute was not resolved; the final protocols acknowledged both positions while establishing that prevention through physical segregation, sterilization, and decontamination would form the legal and architectural basis of modern medicine.

The congress produced five binding resolutions. The first established that all hospital design henceforth would include physically isolated surgical clean wards with separate ventilation systems and controlled access. The second required that all surgical instruments and dressings be sterilized by autoclaving, with disposable materials preferred where practicable. The third mandated national governments establish food and water inspection regimes meeting Geneva standards, enforced by criminal penalty for violation. The fourth created the Geneva Sanitary Bureau as a permanent international body to monitor infection statistics and audit compliance with established protocols. The fifth established that serum therapy, then limited to diphtheria antitoxin and experimental preparations, would receive priority for development as a systemic alternative to chemical drugs.

The minutes note that the congress heard testimony from Richard Reinhardt of the Institute for the History of Bacteriology on the statistical foundations of asepsis maximalism. Reinhardt presented data from six German hospitals showing that infection rates in surgical wards varied inversely with the stringency of sterilization protocols and directly with physical isolation of patients. His analysis suggested that every degree of separation between uninfected and infected patients reduced post-operative bacterial invasion by measurable amounts. The delegates adopted Reinhardt's metrics as the basis for the Geneva Standards.

Extensive sections address the economics of prevention. The azo drug manufacturers, represented by delegations from Bayer AG and several French producers, warned against protocols requiring disposable materials on every surgical case, arguing that such expense would be unsustainable. The minutes record that hospital administrators from wealthy nations acknowledged this but insisted that capital investment in clean wards would prove less expensive than managing epidemic infection after it began. The congress sided with the hospital administrators, establishing that prevention would be treated as a capital cost rather than an ongoing drug expense.

The final section records the formal establishment of the Geneva Sanitary Bureau and the appointment of its first director-general, a Swiss epidemiologist. The minutes note that the bureau would have authority to inspect hospital facilities, audit sterilization methods, investigate infection outbreaks crossing borders, and publish annual statistics. The congress granted no power to mandate treatment — that remained within national sovereignty — but enshrined inspection and statistical transparency as obligations of member nations.

The congress concluded with a statement that bacterial infection remained the central medical problem of the age and that without systemic chemical cure, the only available strategy was the prevention of infection through institutional and legal means. The minutes were published in French and English in 1953 by the Geneva Sanitary Bureau and have remained the foundational document of infection-control doctrine in the present day.